Residue depletion of imidocarb in swine tissue

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 6, 2009, Pages 2324-2328

  Wang, Zhongjie ^a,b   Li, Xiubo ^c   Su, Dan ^b   Li, Yijing ^d   Wu, Lianyong ^e   Wang, Yongjian ^a   Wu, Wenxue ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b Shandong Vocational Animal Science and Veterinary College   (China)

^c INSTITUTE OF PLANT PROTECTION   (China)

^d SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^e QiLu Animal Health Products Co Ltd   (China)

Author keywords

HPLC UV; Imidocarb; Intramuscular administration; Residue depletion; Swine

Indexed keywords

ANTIPROTOZOAL AGENT; DRUG RESIDUE; IMIDOCARB;

ADIPOSE TISSUE; ANIMAL; ARTICLE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIVER; MAXIMUM ALLOWABLE CONCENTRATION; MEAT; MUSCLE; SWINE;

ADIPOSE TISSUE; ANIMALS; ANTIPROTOZOAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESIDUES; IMIDOCARB; KIDNEY; LIVER; MAXIMUM ALLOWABLE CONCENTRATION; MEAT; MUSCLES; SWINE;

SUIDAE;

EID: 64549144201     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf803251j     Document Type: Article

References (32)

1. Kuttler, K. L.: Johnson, L. W. Chemoprophylactic activity of imidocarb, diminazene and oxytetracycline against Babesia bovis and B. bigemina. Vet. Parasitol. 1986, 21 (2), 107-118.
2. Kuttler, K. L. The effect of imidocarb treatment on Babesia in the bovine and the tick (Boophilus microplus). Res. Vet. Sci. 1975, 18, 198.
3. Thompson, K. C.; Todorovic, R. A.; Mateus, G. Methods to improve the health of cattle in the tropics: Immunisation and chemoprophylaxis against haemoparasitic infections. Trop. Anim. Health Prod 1978, 10 (2), 75-81.
4. Sevinc, F.; Turgut, K.; Sevinc, M.; Ekici, O. D.; Coskun, A.; Koc, Y.; Erol, M.; lca. A. Therapeutic and prophylactic efficacy of imidocarb dipropionate on experimental Babesia ovis infection of lambs. Vet. Parasitol. 2007, 149 (1-2), 65-71.
5. McHardy, N.; Woollon, R. M.; Clampitt, R. B.; James, J. A.; Crawley, R. J. Efficacy, toxicity and metabolism of imidocarb dipropionate in the treatment of Babesia ovis infection in sheep. Res. Vet. Sci. 1986, 41, 14-20.
6. Frerichs, W. M.; Allen, P. C.; Holbrook, A. A. Equine piroplas-mosis (Babesia equi): Therapeutic trials of imidocarb dihydro-cloride in horses and donkeys. Vet. Rec. 1973, 93, 73-75.
7. Bourdoiseau, G. Canine babesiosis in France. Vet. Parasitol. 2006, 138 (1-2), 118-125.
8. Penzhorn, B.; Lewis, L.; de Waal, B. D.; López Rebollar, D. T. Sterilization of Babesia canis infections by imidocarb alone or in combination with diminazene. J. S. Afr. Vet. Assoc. 1995, 66 (3), 157-159.
9. Wilson, A. J.; Parker, R.; Parker, M.; Hall, W. T.; Trueman, K. F. Chemotherapy of acute bovine anaplasmosis. Aust. Vet. J. 1979, 55 (2), 71-73.
10. Coetzee, J. F.; Apley, M. D.; Kocan, K. M.: Jones, D. E. Flow cytometric evaluation of selected antimicrobial efficacy for clearance of Anaplasma marginale in short-term erythrocyte cultures. J. Vet. Pharmacol Ther. 2006, 29 (3), 173-183.
11. Matthewman, L. A.; Kelly, P. J.; Brouqui, P.; Raoult, D. Further evidence for the efficacy of imidocarb dipropionate in the treatment of Ehrlichia canis infection. J. S. Afr. Vet. Assoc. 1994, 65 (3), 104-107.
12. Price, J. E.; Dolan, T. T. A comparison of the efficacy of imidocarb dipropionate and tetracycline hydrochloride in the treatment of canine ehrlichiosis. Vet. Rec. 1980, 107 (12), 275-277.
13. Rodrigues, F. H.; Afonso-Cardoso, S. R.; Gomes, M. A.; Beletti, M. E.; Rocha, A.: Guimaraes, A. H.; Candeloro, I.; de Souza, M. A. Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazon-ensis. Vet. Parasitol. 2006, 139 (1-3). 37-46.
14. Purnell, R. E.; Rae, M. C.; Deuk, S. M. Efficacy of imidocarb diproprionate and primaquine phosphate in the prevention of tick-borne disease in imported Hereford heifers in South Korea. Trop. Anim. Health Prod. 1981, 13 (3), 123-127.
15. Purnell, R. E.; Rae, M. C. The use of imidocarb diproprionate for the treatment of Theileria sergenti infections of cattle. Aust. Vet. J. 1981, 57 (5), 224-226.
16. Hung. Ch. A. L. Chemotherapeutic efficacy of imidocarb dipropionate on experimental Eperythrozoon ovis infection in sheep. Trop. Anim. Health Prod. 1986, 18, 97-102.
17. Su, D.; Li, X. B.; Wang, Z. J.; Wang, L.: Wu, W. X.; Xu, J. Q. Pharmacokinetics and bioavailability of imidocarb dipropionate in swine. J. Vet. Pharmacol. Ther. 2007, 30 (4), 366-370.
18. Song, J. C.; Zhang, S. F.; Xu, Y. T.; Jin, C. M. Comparative efficacy of diminazene diaceturate, imidocarb dipropionate and erythromycin thiocyanate against Eperythrozoon suis infections in swine. Heilongjiang, J. Anim. Sci. Vet. Med. 2003, 8, 50-51.
19. Coldham, N. G.; Moore, A. S.; Sivapathasundaram, S.; Sauer, M. J. Imidocarb depletion from cattle liver and mechanism of retention in isolated bovine hepatocytes. Analyst 1994, 9, 2549-2552.
20. Coldham, N. G.; Moore, A. S.; Dave, M.; Graham, P. J.; Sivapathasundaram, S.; Lake, B. G.; Sauer, M. J. Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity. Drug Metab. Dispos. 1995, 23, 501-505.
21. Tarbin, J. A.; Tyler, D.; Shearer, G. The use of ion-exchange as a clean-up procedure for the trace residue analysis of veterinary drugs in animal tissues. Residues Veterinary Drugs Food. Proceedings of the 2nd European Residue Conference, 1993: Vol. 2, pp 659-663.
22. Aliu, Y. O.; Davis, R. H.; Camp, B. J.; Kuttler, K. L. Absorption, distribution and excretion of imidocarb dipropionate in sheep. Am. J. Vet. Res. 1977, 38, 2001-2007.
23. Abdullah, A. S.; Baggot, J. D. Pharmacokinetics of imidocarb in normal dogs and goats. J. Vet. Pharmacol. Ther. 1983, 6, 195-199.
24. Lai, O.; Belloli, C.; Crescenzo, G.; Ormas, P. Depletion and bioavailability of imidocarb residues in sheep and goat tissues. Vet. Hum. Toxicol. 2002, 44 (2), 79-83.
25. Belloli, C.; Crescenzo, G.; Lai, O.; Carofiglio, V.; Marang, O.; Ormas, P. Pharmacokinetics of imidocarb dipropionate in horses after intramuscular administration. Equine Vet. J. 2002, 34 (6), 625-629.
26. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Center for Veterinary Medicine (CVM). Guidance for Industry, Bioanalytical Method Validation. May, 2001 (available at http://www.fda.gov/cder/guidance/index.htm).
27. CVMP Imidocarb Summary Report (1). EMEA/MRL/444/98-FINAL (www.emea.eu.int). Committee for Medicinal Products, European Medicines Agency, London, U.K., 1998.
28. CVMP Guideline on Validation of Analytical Procedures: Methodology. EMEA/CVMP/VICH/591/98-F1NAL (www.emea.eu. int). Committee for Medicinal Products for Veterinary Use, European Medicines Agency, London, U.K., 1998.
29. CVMP Imidocarb (Extension to Sheep). Summary Report. EMEA/MRL/881/03- FINAL (www.emea.eu.int). Committee for Medicinal Products for Veterinary Use, European Medicines Agency, London, U.K., 2003.
30. Committee for Veterinary Medicinal Products (CVMP). The European Agency for the Evaluation of Medicinal Products. Note for Guidance: Approach towards Harmonization of Withdrawal Period, EMEA/CVMP/036/95, 1995.
31. Moore, A. S.; Coldham, N. G.; Sauer, M. J. A cellular mechanism for imidocarb retention in edible tissues. Toxicol. Lett. 1996. 87, 61-68.
32. Kuttler, K. L.: Johnson, L. W. Chemoprophylactic activity of imidocarb, diminazene and oxytetracycline against Babesia bovis and B. higemina. Vet. Parasitol. 1986, 21 (2). 107-118.